Cheap drugs won't stop scourge of AIDS in South Africa

June 25, 2001

In this issue of CMAJ, Dr. Daniel Ncayiyana, editor of the South African Medical Journal, comments on the state of the HIV/AIDS pandemic in his country. He says his country's government has offered unequivocal support for drugs to treat opportunistic infections due to HIV/AIDS, but has been justifiably cautious about committing to prophylaxis against mother-to-child transmission (MCTC), antiretroviral therapy (ART) and other treatment programs. Dr. Ncayiyana states that it is not clear that South Africa can afford to treat every patient with AIDS, even with greatly reduced drug prices. Secondly, he states it is not feasible to expect South Africa's poorly equipped hospitals and clinics in remote areas to provide the necessary infrastructure for a successful treatment program, and the country lacks the capacity to counsel and test all pregnant women at risk for MTCT. He also states that while ART will undoubtedly help alleviate suffering, it will not help "contain the scourge" of AIDS in South Africa.
-end-
Antiretroviral therapy cannot be South Africa's first priority
-- D.J. Ncayiyana

Contact: Professor Daniel Ncayiyana, Editor, South African Medical Journal, Cape Town, South Africa; tel. 011-27-31-308-5100, email: vice-chancellor@wpogate.mlsultan.ac.za

Canadian Medical Association Journal

Related Aids Articles from Brightsurf:

Developing a new vaccination strategy against AIDS
Infection researchers from the German Primate Center (DPZ) -- Leibniz Institute for Primate Research have in cooperation with international colleagues tested a new vaccination strategy against the HIV-related simian immunodeficiency virus (SIV) in rhesus monkeys.

HIV-AIDS: Following your gut
Researchers find a way to reduce replication of the AIDS virus in the gastrointestinal tract.

A path toward ending AIDS in the US by 2025
Using prevention surveillance data to model rates of HIV incidence, prevalence and mortality, investigators at Brigham and Women's Hospital and Johns Hopkins Bloomberg School of Public Health set targets, specifically a decrease in new infections to 21,000 by 2020 and to 12,000 by 2025, that would mark a transition toward ending the HIV/AIDS epidemic.

What does it take for an AIDS virus to infect a person?
Researchers examined the characteristics of HIV-1 strains that were successful in traversing the genital mucosa that forms a boundary to entry by viruses and bacteria.

How AIDS conquered North America
A new technique that allowed researchers to analyze genetic material from serum samples of HIV patients taken before AIDS was known provides a glimpse of unprecedented detail into the beginnings of the AIDS epidemic in North America.

New research could help build better hearing aids
Scientists at Binghamton University, State University of New York want to improve sensor technology critical to billions of devices made every year.

NY State Department of Health AIDS Institute funds HIV/AIDS prevention in high-risk youth
NewYork-Presbyterian's Comprehensive Health Program and Project STAY, an initiative of the Harlem Heath Promotion Center (HHPC) at Columbia University's Mailman School of Public Health has received two grants totaling more than $3.75 million from the New York State Department of Health AIDS Institute for their continued efforts to prevent HIV/AIDS in at-risk youth.

A new way to nip AIDS in the bud
When new HIV particles bud from an infected cell, the enzyme protease activates to help the viruses infect more cells.

AIDS research prize for Warwick academic
A researcher at the University of Warwick has received international recognition for his contribution to AIDS research.

Insects inspire next generation of hearing aids
An insect-inspired microphone that can tackle the problem of locating sounds and eliminate background noise is set to revolutionize modern-day hearing aid systems.

Read More: Aids News and Aids Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.